HEALTH UTILITIES ASSOCIATED WITH HYPOGLYCEMIC EVENTS IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS RECEIVING BASAL-BOLUS INSULIN THERAPY

被引：1
|
作者：
Ionova, T. [1 ]
Nikitina, T. [1 ]
Kurbatova, K. [2 ]
机构：
[1] Natl Pirogov Med Surg Ctr, Moscow, Russia
[2] Multinatl Ctr Qual Life Res, St Petersburg, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2112
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB73
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [31] Signal Detection for Quantitative Identification of Subgroups of Patients With Type 2 Diabetes Mellitus (T2DM) Likely to Achieve Metabolic Control With Basal Insulin Therapy
    Aroda, Vanita
    Ratner, Robert
    Girard, Manon
    Berria, Rachele
    Vlajnic, Aleksandra
    Stewart, John
    Riddle, Matthew
    DIABETES, 2012, 61 : A288 - A288
  • [32] Assessment of Adverse Renal Effects in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Patel, Shrita M.
    Hickman, Mary A.
    Frederich, Robert
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Huyck, Susan
    Mancuso, James P.
    DIABETES, 2018, 67
  • [33] Alternate therapy of Type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae)
    Akash, M. S. H.
    Rehman, K.
    Rasool, F.
    Sethi, A.
    Abrar, M. A.
    Irshad, A.
    Abid, A.
    Murtaza, G.
    JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, 5 (31): : 6885 - 6889
  • [34] Treatment Patterns and Characteristics of Patients with Type 2 Diabetes (T2D) Managed with Basal-Bolus Therapy in the
    Van Brunt, Kate
    Curtis, Bradley H.
    Chalkiadaki, Corina
    Balogh, Elemer
    Ivanyi, Tibor
    Raluy, Mireia
    Maclachlan, Sharon
    DIABETES, 2015, 64 : A696 - A697
  • [35] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hancu, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
  • [36] Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal-Bolus Therapy
    Langer, Jakob
    Wolden, Michael L.
    Shimoda, Seiya
    Sato, Miki
    Araki, Eiichi
    DIABETES THERAPY, 2019, 10 (04) : 1347 - 1356
  • [37] Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study
    Edelman, Steven, V
    Ermakova, Anastasia
    Xiong, Yan
    Sieradzan, Ray
    Taylor, Stephanie D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (12): : 1420 - 1431
  • [38] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
    Kapustin, J.
    Anderson, J. E.
    Reid, T.
    Rhinehart, A.
    Brunton, S.
    Stewart, J.
    Zhou, W.
    Dex, T.
    Kazemi, M.
    Vlajnic, A.
    Dalal, M.
    DIABETOLOGIA, 2014, 57 : S440 - S440
  • [39] ADAPTIVE BASAL-BOLUS ADVISOR FOR INSULIN TREATED PEOPLE WITH TYPE 2 DIABETES
    Panagiotou, M.
    Brigato, L.
    De Galan, B.
    Mougiakakou, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A90 - A91
  • [40] Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM)
    Weinzimer, SA
    McKnight, WJ
    Murphy, K
    Jawad, AF
    Celona-Jacobs, N
    Haque, A
    Katz, LEL
    DIABETES, 2001, 50 : A68 - A68
12345